Apotex and Strides to merge Australia generics business
15-05-2018
Eli Lilly targets more than 30 generics in Effient patent case
17-03-2014
PENpics Studio / Shutterstock.com
Azurity Pharmaceuticals has sued Massachusetts drug company Bionpharma, claiming that its generic of Azurity’s Epaned product infringes on a brand new patent.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Azurity Pharmaceuticals Bionpharma, Enalapril Maleate, US District Court for the District Of Delaware, FDA
